-
1
-
-
0025097994
-
Platelets and thrombolytic therapy
-
Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990;322:33-42.
-
(1990)
N Engl J Med
, vol.322
, pp. 33-42
-
-
Coller, B.S.1
-
2
-
-
14344270942
-
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention
-
Collet JP, Montalescot G, Lesty C, et al. Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation 2001; 103:2328-2331.
-
(2001)
Circulation
, vol.103
, pp. 2328-2331
-
-
Collet, J.P.1
Montalescot, G.2
Lesty, C.3
-
3
-
-
0035162774
-
Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis
-
Collet JP, Montalescot G, Lesty C, et al. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arterioscler Thromb Vasc Biol 2001;21:142-148.
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 142-148
-
-
Collet, J.P.1
Montalescot, G.2
Lesty, C.3
-
4
-
-
0025118412
-
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction
-
TAMI Study Group
-
Ohman EM, Califf RM, Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. Circulation 1990;82:781-791.
-
(1990)
Circulation
, vol.82
, pp. 781-791
-
-
Ohman, E.M.1
Califf, R.M.2
Topol, E.J.3
-
5
-
-
0030748125
-
Mechanisms initiating platelet thrombus formation
-
Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997;78:611-616.
-
(1997)
Thromb Haemost
, vol.78
, pp. 611-616
-
-
Ruggeri, Z.M.1
-
6
-
-
0023893546
-
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs
-
Yasuda T, Gold HK, Fallon JT, et al. Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J Clin Invest 1988;81:1284-1291.
-
(1988)
J Clin Invest
, vol.81
, pp. 1284-1291
-
-
Yasuda, T.1
Gold, H.K.2
Fallon, J.T.3
-
7
-
-
0033054733
-
New thrombolytic strategy: Bolus administration of tPA and urokinase-fibrinogen conjugate
-
Maksimenko AV, Tischenko EG. New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate. J Thromb Thrombolysis 1999;7:307-312.
-
(1999)
J Thromb Thrombolysis
, vol.7
, pp. 307-312
-
-
Maksimenko, A.V.1
Tischenko, E.G.2
-
8
-
-
0031799150
-
Mechanism of rethrombosis after thrombolytic therapy: Angioscopic findings and investigation of the coagulation system in dogs
-
Maki A, Shirato C, Ohguchi M, et al. Mechanism of rethrombosis after thrombolytic therapy: angioscopic findings and investigation of the coagulation system in dogs. Angiology 1998;49:447-453.
-
(1998)
Angiology
, vol.49
, pp. 447-453
-
-
Maki, A.1
Shirato, C.2
Ohguchi, M.3
-
9
-
-
0035849569
-
Rescue treatment with abciximab in acute ischemic stroke
-
Lee KY, Heo JH, Lee SI, Yoon PH. Rescue treatment with abciximab in acute ischemic stroke. Neurology 2001;56:1585-1587.
-
(2001)
Neurology
, vol.56
, pp. 1585-1587
-
-
Lee, K.Y.1
Heo, J.H.2
Lee, S.I.3
Yoon, P.H.4
-
10
-
-
0033152273
-
Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
-
The TIMI 14 Investigators
-
Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999;99:2720-2732.
-
(1999)
Circulation
, vol.99
, pp. 2720-2732
-
-
Antman, E.M.1
Giugliano, R.P.2
Gibson, C.M.3
|